If you have blood in stool, anemia, or a strong family history of IBD, dont self-label
The peptide's therapeutic potential extends beyond mere neuroprotection to actual neural repair and regeneration
Among these, liraglutide in the LEADER study, semaglutide in the SUSTAIN-6, albiglutide in the Harmony Outcomes, dulaglutide in the REWIND, and efpeglenatide in the AMPLITUDE-O exhibited significant beneficial effects on 3-point major adverse cardiac events (3P-MACE: death from CV disease, non-fatal myocardial infarction, and non-fatal stroke), the primary end point of each study, compared to the placebo group, respectively
Under the expert care of Aloni Le, DNP, ARNP, FNP-C , we bring together years of clinical experience, advanced medical knowledge, and a true passion for patient-centered care